Indian Indices
Global Indices
Commodity (SPOT)
Currency (SPOT)
22 Jan 2017 | 1:49 AM
 

Natco Pharma Ltd. Share Price Live (BSE)
0

BSE Code: 524816 | NSE Symbol: NATCOPHARM
631.50
-9.35
(-1.45 %)
20 Jan 2017 | 04:01 PM
Change company
  • Open (Rs)
    640.00
  • Prev. close (Rs.)
    640.85
  • High (Rs.)
    640.00
  • Low (Rs.)
    621.05
  • 52W H (Rs.)
    703.95
  • 52W L (Rs.)
    390.00
  • Volume (Rs.)
    14872
  • MCap (Rs in Cr.)
    11,007.56
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
8.91
Operating Margin (%)
23.62
Gross Profit Margin (%)
19.16
Net Profit Margin (%)
13.59
Total Debt/Equity
0.08
Dividend payout Ratio (Net Profit)
16.88
Earning Retention Ratio
83.49

News

06 Jan 2017 - 14:36:00-Natco Pharma Ltd today said it has received final approval from USFDA for Bendamustine injection...
02 Jan 2017 - 17:04:00-Drug maker Natco Pharma Ltd on Monday said it has launched the first generic version of Sofosbuvir 4...
12 Dec 2016 - 11:13:00-Pharma major Natco Pharma Ltd on Monday said that the company through its marketing partner Alvogen ...
29 Nov 2016 - 15:00:00-Natco Pharma said that it has received final approval of Abbreviated New Drug Application (ANDA) con...

Announcements

10-Jan-2017
Natco Pharma - Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations 2015 for Quarter ended December 3
07-Jan-2017
Natco Pharma - Shareholding for the Period Ended December 31 2016
06-Jan-2017
Natco Pharma - Natco receives final approval for Generic Bendamustine HCL Powder for USA Market
02-Jan-2017
Natco Pharma - NATCO launches VELPANAT in Nepal- 1st generic version of Sofosbuvir 400mg/Velpatasvir 100mg fixed dose combina
12-Dec-2016
Natco Pharma - Natco Launches the First Generic equivalent of Tamiflu® Capsules in the USA Market

Religare Research

20 Jan 2017 | 06:00 PM
PTC India Financial Services (PFS) is a non-banking finance company promoted by PTC India (60% stake...
20 Jan 2017 | 06:00 PM
Nifty index traded sideways for most past of the passing week but steep sell-off on Friday i.e. 20th...
20 Jan 2017 | 03:33 PM
The Union Budget is round the corner, and before we try to gaze at what it might have in store, ther...
20 Jan 2017 | 10:23 AM
Agri Technical report

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
4,00,000 90.05 31.94 0.13
4,00,000 90.05 122.67 0.12
4,00,000 90.05 127.53 0.13
4,00,000 90.05 46.41 0.13
1,60,000 35.89 106.62 0.56

Shareholding Pattern

       
Promotors51.24%
Mutual Funds/UTI5.33%
FI/Banks3.92%
Insurance3.92%
FII16.76%
Government0.00%
Others3.50%

Peer Group

Company Intraday Graph
 Dr. Reddy`s Laboratories Ltd.
2,936.00(-0.12)
3294
 GlaxoSmithKline Pharmaceuticals Ltd.
2,752.10(0.07)
3317
 Ajanta Pharma Ltd.
1,780.00(0.39)
3790
 Piramal Enterprises Ltd.
1,764.00(-3.81)
3356

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Natco Pharma Ltd.43.5040.8045.50
NIFTY(S&P CNX)266.95-350.05-160.75
BSE SENSEX726.52-1,095.34-881.39
BSE 500465.82-538.8935.24

Corporate Details

Key Personal
A K S Bhujanga Rao
Director & President (R&D and Tech.)
A K S Bhujanga Rao
President & Director
D Linga Rao
Director & President (Tech. Affairs)
Key Address
Registered Office
Natco House Road No.2 Banjara Hills,Hyderabad,Telangana

Tel:040-23547532, Fax:040-23548243

investors@natcopharma.co.in
http://www.natcopharma.co.in
Registrar Office
Venture Capital & Corporate Investments Pvt. Ltd.
Add. :No. 12-10-167 Bharat Nagar

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Natco Pharma Ltd. that will help you decide whether to buy, sell or hold Natco Pharma Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Natco Pharma Ltd.

Regenerate OTP
Thank You for your interest in Religare Online. Our Representative will get in touch with you shortly.